Evidence map›Paper›PMID 28031838›Full record

ArticleRespirology case reports2016

Stromal micropapillary predominant lung adenocarcinoma: A rare histological phenotype with poor prognosis.

Takamitsu Hayakawa, Shogo Tajima, Masaru Tsukui, Yusuke Takanashi, Hiroshi Neyatani, Kazuhito Funai

Open access · goldAbstract readCase Reports
In one paragraph

Article in Respirology case reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Expansion of the Concept of Micropapillary Adenocarcinoma to Include a Newly Recognized Filigree Pattern as Well as the Classical Pattern Based on 1468 Stage I Lung Adenocarcinomas.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2019
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Takamitsu HayakawaDepartment of Thoracic Surgery Fujieda Municipal General Hospital Fujieda Japan.
Shogo TajimaDepartment of Pathology Fujieda Municipal General Hospital Fujieda Japan.
Masaru TsukuiDepartment of Respiratory Fujieda Municipal General Hospital Fujieda Japan.
Yusuke TakanashiDepartment of Thoracic Surgery Fujieda Municipal General Hospital Fujieda Japan.
Hiroshi NeyataniDepartment of Thoracic Surgery Fujieda Municipal General Hospital Fujieda Japan.
Kazuhito FunaiDepartment of Surgery 1 Hamamatsu University School of Medicine Hamamatsu Japan.
Fujieda Municipal General Hospital · JPHamamatsu University School of Medicine · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An extremely rare case of stromal micropapillary predominant lung adenocarcinoma is presented in this study. A 70-year-old woman visited our hospital because of an abnormal shadow on chest X-ray. Chest computed tomography revealed a nodule in the left lower lobe and a mass in the left upper lobe. She underwent an exploratory thoracotomy owing to the suspicion of advanced lung cancer. Pathological examination of the left lower lobe nodule revealed tumour cells with more than half the tumour cells showing stromal micropapillary pattern (SMP), consisting of tumour cells invading the fibrotic stroma. In general, micropapillary adenocarcinomas in the lung form an aerogenous micropapillary pattern (AMP), in which tumour cells float in alveolar spaces. Because the prognosis of SMP lung adenocarcinomas is known to be worse than that of AMP lung adenocarcinomas and have a high frequency of epidermal growth factor receptor mutations, the discrimination of SMP from AMP is important for both pathologists and clinicians.

Indexed as

EGFR mutationlung adenocarcinomapoor prognosisstromal micropapillary pattern

Identifiers

PMID28031838
PMCPMC5167289
OpenAlexW2551285011

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.